# Compounded GLP-1 in FAERS: Reporting Odds for Errors and Contamination

A FAERS analysis compared reports involving compounded and approved GLP-1 products, including preparation errors and contamination.

Publisher: Buy This GLP Editorial Team
Canonical: https://buythisglp.com/research/what-the-adverse-event-database-says
Updated: 2026-11-15
Published: 2026-09-15

[← Research](https://buythisglp.com/research)

Safety

# Compounded GLP-1 in FAERS: Reporting Odds for Errors and Contamination

A FAERS study found higher reporting odds for some events with compounded GLP-1 products. These reports cannot estimate patient risk.

Editorial profile: [Carla Medina](https://buythisglp.com/authors/carla-medina)[Buy This GLP Editorial Team](https://buythisglp.com/about)September 20263 min readUpdated November 2026

**Research, not medical advice.** Buy This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://buythisglp.com/methodology) and [terms](https://buythisglp.com/terms).

FDA reports of [dosing errors with compounded semaglutide](https://buythisglp.com/research/can-you-overdose-on-compounded-semaglutide) describe specific incidents. This analysis compared the mix of reports for compounded and FDA-approved GLP-1 products in the FDA Adverse Event Reporting System (FAERS) [\[1\]](https://buythisglp.com/research/what-the-adverse-event-database-says#ref-1).

## What was reported

Of 81,078 GLP-1 reports from 2018 to 2024, 707 involved compounded products. The reporting odds ratio was 48.92 for preparation errors (95% CI 12.63 to 189.60) and 19.00 for contamination (95% CI 4.24 to 85.03) [\[1\]](https://buythisglp.com/research/what-the-adverse-event-database-says#ref-1).

Hospitalization also had higher reporting odds (2.35). Administration and dosing errors had lower reporting odds in this analysis. Those categories can be reported differently across products.

## How to read an FDA safety report

A reporting odds ratio compares the relative prominence of an event in submitted reports. The database lacks a reliable count of everyone treated. FDA cautions that the reports alone cannot establish causation or establish one product's safety relative to another [\[2\]](https://buythisglp.com/research/what-the-adverse-event-database-says#ref-2).

FDA separately describes concerns including errors and inadequate temperature control in some shipped compounded products [\[3\]](https://buythisglp.com/research/what-the-adverse-event-database-says#ref-3). Contact the dispensing pharmacist or prescriber if the instructions or condition of a shipment raise questions.

## Frequently asked

Does a reporting odds ratio measure the chance of harm?

It compares patterns among submitted reports. The number of people treated and their actual chance of harm cannot be derived from it.

## Sources

1.  \[1\] McCall KL, et al. (2026). Safety analysis of compounded GLP-1 receptor agonists: a pharmacovigilance study using the FDA adverse event reporting system Expert Opinion on Drug Safety. [Source](https://pubmed.ncbi.nlm.nih.gov/40285721/)
2.  \[2\] U.S. Food and Drug Administration (2026). Understanding CDER’s Postmarket Safety Surveillance Programs and Public Data FDA. [Source](https://www.fda.gov/drugs/cder-conversations/understanding-cders-postmarket-safety-surveillance-programs-and-public-data)
3.  \[3\] U.S. Food and Drug Administration (2026). FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss FDA. [Source](https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss)

## More in Safety

-   [
    
    Follow the prescription · Storefront → pharmacy → label
    
    ### How to Verify an Online Pharmacy for GLP-1 Medication
    
    ](https://buythisglp.com/research/how-to-verify-online-pharmacy-for-glp1)
-   [
    
    Warm delivery? Pause first. · Save the evidence. Call the pharmacy.
    
    ### Semaglutide Arrived Warm? What to Do Before Using It
    
    ](https://buythisglp.com/research/semaglutide-arrived-warm)
-   [
    
    503A pharmacy · 503B facility · Prescription · per patient · or office stock · CGMP · exempt · required · Oversight · state license · FDA, risk-based · Adverse events · no FDA duty · must report · FDA approval · no · no
    
    ### 503A vs 503B Pharmacy Rules for Compounded GLP-1s
    
    ](https://buythisglp.com/research/503a-vs-503b-pharmacy-compounded-glp1)
